Assert-IQ vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

DeepRhythmAI

by Medicalgorithmics S.A.

AI Verdict

Assert-IQ is an insertable cardiac monitor system providing long-term, continuous data acquisition and monitoring for arrhythmia detection. DeepRhythmAI, conversely, is a cloud-based AI algorithm designed to analyze and classify existing ECG data from various devices with high accuracy and efficiency. While both aim to improve cardiac arrhythmia diagnostics, Assert-IQ focuses on generating long-term data via an implanted device, whereas DeepRhythmAI specializes in the advanced analysis of already-collected ECG data.

Choose Assert-IQ if…

Choose Assert-IQ if your patient requires exceptionally long-term, continuous cardiac monitoring for up to six years, particularly for detecting infrequent or elusive arrhythmias that might be missed by shorter-term external monitoring. This insertable cardiac monitor is ideal for patients needing discreet, proactive arrhythmia detection with remote monitoring capabilities and patient-activated symptom logging.

View Assert-IQ →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your practice seeks to significantly enhance the accuracy and efficiency of cardiac arrhythmia detection and classification from existing or newly acquired ECG data. This cloud-based, device-agnostic AI algorithm is best suited for streamlining clinical workflows, reducing missed diagnoses, and accelerating ECG reporting across various healthcare settings.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	DeepRhythmAI
Pricing	Enterprise	Enterprise
Deployment	Hybrid	Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI's cloud-based, device-agnostic approach and focus on streamlining clinical workflows for faster ECG reporting and analysis offer broad usability benefits for clinicians across various existing setups. Assert-IQ's usability is more tied to its specific insertable device and patient-centric features like the activator.

Clinical Value

DeepRhythmAI

DeepRhythmAI provides strong, quantifiable claims of superior accuracy and a significant reduction in missed diagnoses (14x to 114x fewer), directly impacting clinical outcomes through improved diagnostic precision. While Assert-IQ offers valuable long-term continuous monitoring, DeepRhythmAI's diagnostic superiority claims are more compelling for overall clinical value.

Pricing & Value

DeepRhythmAI

Both tools lack transparent public pricing details and do not offer free trials, making a direct cost comparison impossible. However, DeepRhythmAI explicitly quantifies its value proposition with claims of up to a 65% increase in efficiency and a substantial reduction in missed diagnoses, offering a clearer picture of potential return on investment.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI's explicit availability of an API significantly enhances its integration capabilities within diverse enterprise IT environments, allowing for greater flexibility in data exchange and workflow automation. Its cloud-based deployment and stated target market from solo to large health systems also demonstrate strong adaptability for various enterprise scales.

Innovation

DeepRhythmAI

DeepRhythmAI showcases a higher degree of innovation in its core technology by leveraging advanced AI models like CNNs and Transformers, trained on an exceptionally large dataset of over 250 billion annotated heartbeats. This focus on cutting-edge AI methodology for superior diagnostic accuracy represents a significant technological advancement in the field.

Support & Docs

Assert-IQ

Abbott Medical, as a global leader in medical devices with a long-standing history since 1888, is inherently expected to possess a more extensive and robust support infrastructure and comprehensive documentation compared to Medicalgorithmics S.A. While both are established, Abbott's scale and resources likely translate to superior support capabilities.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	DeepRhythmAI
Product Name	Assert-IQ	DeepRhythmAI
Company	Abbott Medical	Medicalgorithmics S.A.
Core Functionality	Long-term, continuous monitoring and advanced arrhythmia detection via an Insertable Cardiac Monitor (ICM) system.	FDA-cleared, cloud-based AI algorithm for cardiac arrhythmia detection and classification from ECG data.
API Availability	no	yes
Target Customer Size	Large health systems, hospitals, cardiology clinics	Solo to large health systems
Key Technology/Methodology	Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform	AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats
Monitoring/Analysis Scope	Long-term continuous cardiac monitoring (up to 6 years)	Revolutionizes cardiac arrhythmia detection and classification from ECG data

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and DeepRhythmAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in how Assert-IQ and DeepRhythmAI acquire and analyze cardiac data?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system that provides long-term, continuous monitoring for up to 6 years through a minimally invasive device implanted subcutaneously. DeepRhythmAI is a cloud-based AI algorithm that analyzes ECG data from various external devices, such as Holter, event recorders, and mobile cardiac telemetry, to detect and classify arrhythmias.

Can you describe the AI capabilities and the scope of arrhythmia detection for each system?

Assert-IQ features advanced AI algorithms designed to reduce false positives for AF and Pause episodes while maintaining high sensitivity, providing comprehensive arrhythmia detection over long periods. DeepRhythmAI employs AI-powered detection and classification using CNN and Transformer models, trained on over 250 billion annotated heartbeats, to accurately identify a wide range of cardiac arrhythmias.

What are the reported benefits regarding diagnostic accuracy and clinical efficiency for each tool?

DeepRhythmAI claims to reduce missed diagnoses of critical arrhythmias by 14 times compared to technician analysis and can increase clinical workflow efficiency by up to 65% through faster ECG reporting. Assert-IQ focuses on advanced arrhythmia detection algorithms, proactive clinician alerts, and remote monitoring capabilities to aid in diagnosing and managing patients with suspected heart rhythm disorders.

What are the differences in the target user base and the scale of health systems each tool is designed for?

Assert-IQ is primarily designed for large health systems, hospitals, and cardiology clinics. DeepRhythmAI targets a broader range of users, from solo practitioners to large health systems, due to its device-agnostic and cloud-based nature.

Are there differences in the duration of monitoring offered by these tools?

Assert-IQ provides long-term continuous cardiac monitoring for up to 6 years. DeepRhythmAI analyzes ECG data, including from long-term recordings up to 30 days, but does not offer an insertable device for continuous long-term monitoring itself.

Do these tools offer options for data export and integration with existing systems?

Both Assert-IQ and DeepRhythmAI offer data export capabilities. DeepRhythmAI also provides an API for integration with various ECG devices and third-party software, whereas Assert-IQ uses Bluetooth Low Energy for data transmission to its cloud platform.